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changes in fatigue rate (r = 0.633, p = 0.06). No changes 
(p = 0.607) were observed in brain carnosine content. 
Following supplementation, no differences were noted in 
2.5 km run, 1-min sprint, repeated sprint, or marksman-
ship performance, but participants in BA significantly 
(p = 0.044) improved their time for the 50-m casualty 
carry and increased their performance (p = 0.022) in the 
SST compared to PL. In summary, 30-days of BA ingestion 
can increase muscle carnosine content and improve aspects 
of military specific performance. Although cognitive per-
formance was significantly greater in participants consum-
ing BA compared to placebo, current study methods were 
unable to detect any change in brain carnosine levels, thus, 
the precise mechanism underlying these effects remains 
elusive.
Keywords Histidine-related compounds · Amino acids · 
Exercise · Supplements
Introduction
Increases in the concentration of histidine containing 
dipeptides within skeletal muscle have been demonstrated 
to have ergogenic potential by increasing the muscles abil-
ity to buffer elevations in hydrogen ion (H+) concentra-
tions (Harris et al. 1990). Carnosine, anserine, balenine, 
and homocarnosine are histidine containing dipeptides that 
are widely distributed in vertebrate tissue including skeletal 
muscle, heart and brain. Carnosine, anserine and balenine 
are comprised of the amino acids l-histidine and β-alanine 
and differ in regards to where the methylation on the imi-
dazole ring appears on the l-histidine molecule (carnosine 
is non-methylated, while anserine and balenine are methyl-
ated) (Boldyrev et al. 2013). It is the imidazole ring of the 
Abstract The purpose of this study was to examine the 
effect of β-alanine (BA) ingestion on tissue carnosine levels 
and the impact such changes would have on combat spe-
cific activity. Eighteen soldiers (19.9 ± 0.8 year) from an 
elite combat unit were randomly assigned to either a BA 
or placebo (PL) group. Before and following a 30-day sup-
plementation period carnosine content of the gastrocne-
mius muscle and brain was determined by proton magnetic 
resonance spectroscopy. During each testing session, par-
ticipants performed military relevant tasks that included a 
2.5 km run, a 1-min sprint, 50-m casualty carry, repeated 
30-m sprints with target shooting, and a 2-min serial sub-
traction test (SST) to assess cognitive function under stress-
ful conditions. A significant elevation (p = 0.048) in mus-
cle carnosine content was noted in BA compared to PL. 
Changes in muscle carnosine content was correlated to 
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histidine containing dipeptide that regulates buffering activ-
ity. However, only carnosine is found in human skeletal tis-
sue, with small concentrations also reported in the olfac-
tory bulb of the brain (Boldyrev et al. 2013). Considering 
that both histidine and carnosine synthetase (the enzyme 
responsible for the synthesis of carnosine) are found in 
high concentrations in skeletal muscle, it is believed that 
β-alanine is the rate-limiting step in carnosine formation 
(Derave et al. 2010).
β-Alanine can be endogenously synthesized in small 
concentrations by hepatic uracil degradation. However, it 
is not synthesized in sufficient concentrations to cause an 
increase in muscle carnosine synthesis (Harris et al. 2006). 
Dietary ingestion of β-alanine may result in a transient ele-
vation in muscle carnosine synthesis, but it does not pro-
vide the consistent transport of β-alanine into the muscle 
that will result in significant changes in muscle carnosine 
concentrations (Harris et al. 2006). Evidence has been quite 
convincing that when β-alanine is provided as a dietary 
supplement for 4–10 weeks, significant increases in muscle 
carnosine concentrations occur (Baguet et al. 2009, 2010; 
Harris et al. 2006; Hill et al. 2007). Further, elevations in 
muscle carnosine are associated with significant perfor-
mance improvements during high-intense physical activity 
(Hill et al. 2007; Hoffman et al. 2008; Van Thienen et al. 
2009).
Scientific examination of β-alanine supplementation has 
focused on its ability to increase muscle carnosine concen-
trations and enhance muscle buffering capacity. However, 
carnosine appears to have a broader biological role, and has 
been proposed to serve as an antioxidant, antiglycating and 
ion-chelating agent suggesting that it may have a potential 
role as a neuro-protector during oxidative stress (Boldyrev 
et al. 2010; Hipkiss et al. 1998; Kohen et al. 1988). How-
ever, only one study is known that has examined the effect 
of β-alanine ingestion on changes in carnosine concentra-
tions in the brain, and this study examined a rodent model. 
Murakami and Furuse (2010) reported an increase of carno-
sine concentrations in the cerebral cortex and hypothalamus 
in mice provided with a daily ingestion of β-alanine under 
stressful conditions. Increases in brain carnosine concentra-
tions were also associated with elevations in brain-derived 
neurotrophic factor (BDNF) and a decrease in 5-hydroxyin-
doleacetic acid concentrations (a metabolite of serotonin) 
in the hippocampus. In addition to the changes in brain 
metabolites, the authors also reported an improved time 
in a maze containing anxiety producing compounds, sug-
gesting that β-alanine ingestion may have anxiolytic-like 
effects (Murakami and Furuse 2010). To date, changes in 
brain carnosine concentrations from β-alanine ingestion in 
a human study has not been examined.
The lack of investigations focusing on increases in brain 
carnosine concentrations is likely related to the previous 
necessity to use invasive techniques to measure carnos-
ine concentrations (e.g., biopsy). However, recent techno-
logical advances using magnetic resonance spectroscopy 
(MRS) has resulted in an effective and valid method to 
measure carnosine concentrations in tissue (Özdemir et al. 
2007). As discussed earlier, carnosine content in the human 
brain has been found only in the olfactory bulb (Boldyrev 
et al. 2013), and present understanding suggests that the 
major histidine dipeptide found in the human brain is 
homocarnosine (Boldyrev et al. 2013). Homocarnosine is 
an analog of carnosine, in which the β-alanine molecule 
is replaced by γ-aminobutyric acid (GABA). Limitations 
with MRS technology though make it difficult to differ-
entiate between carnosine and homocarnosine (Boldyrev 
et al. 2013). However, if β-alanine is provided as a supple-
ment, while GABA ingestion remains similar for all par-
ticipants, it can be postulated that any changes noted in the 
spectrum would be due to an increase in carnosine and not 
homocarnosine.
If brain carnosine concentrations can be shown to 
increase in humans, it may provide a benefit in maintaining 
focus, alertness and cognitive function during highly fatigu-
ing, high intense activity such as that seen in both competi-
tive and tactical athletes. During prolonged, high-intensity 
military training or simulated combat exercises, significant 
decreases in physical and cognitive performance meas-
ures are often reported (Lieberman et al. 2002; Nindl et al. 
2007). In a previous study that has examined the effects 
of β-alanine supplementation in military personnel, Hoff-
man et al. (2014) demonstrated that 4-weeks of β-alanine 
ingestion can enhance jump power performance, marks-
manship and target engagement speed. These improve-
ments occurred following 4-weeks of highly intense train-
ing and followed an acute fatiguing event. However, those 
investigators did not measure changes in muscle or brain 
carnosine concentrations. Thus, the purpose of this study 
was to examine the effect of 30-days of β-alanine inges-
tion on both muscle and brain carnosine concentrations and 




Eighteen male soldiers from an elite combat unit of the 
Israel Defense Forces (IDF) volunteered to participate in 
this double-blind study. Following an explanation of all 
procedures, risks and benefits, each participant provided 
his informed consent to participate in the study. The Hel-
sinki committee of the IDF Medical Corp approved this 
research study. Subjects were not permitted to use any 
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additional dietary supplementation and did not consume 
any androgens or any other performance enhancing drugs. 
Screening for performance enhancing drug use and addi-
tional supplementation was accomplished via a health 
questionnaire completed during participant recruitment. 
Participants were from the same unit and were randomly 
assigned to one of two groups. The randomization proce-
dure involved alternating group assignment of volunteers. 
Using the procedures described by Gravetter and Wallnau 
(1996) for estimating samples sizes for repeated meas-
ures designs, a sample size of 9 of each group resulted in 
a statistical power (1−β) of >0.90 based on the changes in 
sprint performance reported by Van Thienen et al. (2009). 
The first group; (BA; n = 9; age 19.6 ± 0.5 years; height 
1.76 ± 0.05 m; body mass 72.1 ± 4.5 kg) consumed 6.0 g 
of β-alanine per day, while the second group (PL; n = 9; 
age 20.2 ± 1.0 years; height 1.79 ± 0.08 m; body mass 
76.4 ± 6.1 kg) consumed 6.0 g of placebo (rice flour). Dur-
ing the 30-day study period all participants participated 
in the same advanced military training tasks that included 
combat skill development, physical work under pressure, 
navigational training, self-defense/hand-to-hand combat 
and conditioning.
Testing protocol
This randomized, double-blind, placebo-controlled investi-
gation was conducted at the unit’s training facilities, under 
the unit’s regular training protocols and safety regula-
tions. Data collection occurred before (PRE) and following 
(POST) 30-days of supplementation. During each session 
participants performed military relevant tasks that included 
a 2.5 km run, a 1-min sprint, and a 50-m casualty carry. 
In addition, participants performed repeated 30-m sprints 
in combat gear (combat vest with ammunition, helmet, and 
assault rifle). Between each sprint soldiers were tested on 
marksmanship. Immediately following the final sprint and 
target shooting, participants performed a 2-min serial sub-
traction test on the firing range to assess cognitive function 
under stressful conditions (continuous shooting). These 
assessments were based upon previously published inves-
tigations examining military performance responses during 
stressful conditions (Harman et al. 2008; Nindl et al. 2002).
Performance measurements
Muscle and brain carnosine content
Carnosine content of all participants was assessed by pro-
ton magnetic resonance spectroscopy (MRS) in the gastroc-
nemius muscle and the brain. All studies were performed 
on a 3-T system (Ingenia, Philips Medical Systems, Best, 
The Netherlands). Single-voxel, STEAM acquisitions of 
the gastrocnemius medialis muscle of the lower leg were 
carried out using a transmit-receive (16-channel) coil, and 
in the parieto-occipital lobe of the brain using a 32-channel 
receive-only coil. In the leg, the scan parameters were TR/
TM/TE = 2000/12/13 ms, and in the brain 2000/9.4/16 ms. 
Second-order shimming was used giving a full-width-
half-maximum line width of approximately, 25 Hz in 
the calf muscle and 12 Hz in the head. Water suppres-
sion was achieved by applying two bandwidth selective rf 
pulses. The average voxel size for the muscle spectra was 
35 × 18 × 58 mm (AP × RL × FH) and 39 × 41 × 45 mm 
(AP × RL × FH) in the brain. The spectral resolution for 
all spectra was 0.96 Hz, and 400 averages were acquired 
for a scan time of 13:56 min. The spectra were analyzed 
using the Philips SpectroView software.
A 1-l solution of 20 mM l-carnosine (Sigma–Aldrich) 
in 0.1 M potassium phosphate buffer (pH 7.2) was used 
as an external reference phantom for absolute quantifica-
tion. The following equation was used (Baguet et al. 2010; 
Derave et al. 2010) to determine the concentration of car-
nosine in the gastrocnemius muscle using the C2-H peak 
at ~8.0 ppm:
where [Cm], [Cr] are the l-carnosine concentrations in vivo 
and the reference phantom, respectively; Sm, Sr are the esti-
mated peak areas of the C2-H carnosine peak in vivo and 
the reference phantom, respectively; Vm, Vr are the volumes 
of the voxels in vivo and in the reference phantom, respec-
tively; CT1m, CT1r, CT2m, CT2r are the correction factors for 
the T1 and T2 relaxation times in vivo and in the reference 
phantom, respectively; Tm, Tr are the temperatures (°K) in 
vivo and in the reference phantom, respectively. The for-
mulae used to calculate the correction factors were those 
previously recommended (Baguet et al. 2010; Derave et al. 
2010):
The T1, T2 values for the phantom and muscle were 
taken from Baguet et al. (2010). The correction for the coil 
loading was calculated according to the method previously 
described (Soher et al. 1996).
In the brain, the region of the C2-H resonance of car-
nosine at 7.9–8.0 ppm also contains contributions from the 
proton of the n-aspartylaceteate amide group (7.9 ppm) 
and broad resonances from the exchangeable protons from 
purine nucleosides and nucleotides at 8.3 ppm. Therefore, 
changes in the carnosine concentration can only be detected 
by subtraction of the spectra before and after supplement or 
placebo ingestion (Vermathen et al. 2000).
[Cm] = [Cr] ×
SmVrCT1rCT2rTm
SrVmCT1mCT2mTr
CT1 = [1 − exp(−TR/T1)]
CT2 = exp(−TE/T2)
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2.5 km run and 1‑min sprint
These tests simulated a rapid approach to the battlefield. 
Previous research has suggested that a prolonged run with 
sprint is a standard approach to the battlefield (Harman 
et al. 2008). During the run and sprint all participants were 
dressed in shorts, T-shirt and running shoes. Both the run 
and sprint were performed on an asphalt road. All partici-
pants were provided with an individual global positioning 
system (GPS) that they wore in a vest underneath their shirt. 
The GPS unit (MinimaxX, V4.3, Catapult Innovations, Vic-
toria, Australia) was positioned in a posterior pocket on 
the vest situated between the participant’s right and left 
scapula in the upper-thoracic spine region. Information 
on velocity patterns was recorded during the 2.5 km run, 
as well as total distance run during the 1-min sprint. Dur-
ing the 2.5 km run the velocity of the run was divided into 
three operationally distinct thresholds and defined as low 
speed (2.50–3.60 ms−1), moderate speed (3.61–4.43 ms−1) 
or high speed (>4.44 ms−1). In addition, the average veloc-
ity and average heart rate during the 2.5 km run were also 
downloaded from the GPS receiver/transmitters.
During the 1-min sprint peak velocity, average velocity, 
total distance, total distance within 90 % of peak veloc-
ity, and percent decline was downloaded from the GPS 
receiver/transmitters. All data were collected at 10 Hz 
and all analyses were performed with the system software 
provided by the manufacturer. The validity and reliability 
of the GPS technology has been previously demonstrated 
(Varley et al. 2012).
50‑m Casualty carry
This test simulated the rescue of a wounded soldier on the 
battlefield. This test was a modified version of that previ-
ously reported (Harman et al. 2008). All participants began 
the test with a 60 kg manikin on their back, using a “fire-
man’s carry”. On a verbal command the participant sprinted 
with the manikin to a cone 25-m away and returned to the 
starting position. All sprints were performed on a sand and 
dirt surface. All timing was performed with a stopwatch 
that measured time to the nearest 1/100th of a second. The 
same investigator conducted all sprint trials during PRE 
and POST testing.
Repeated sprints and shooting performance
This test mimicked the repeated sprints and shooting 
engagement often encountered on an urban battlefield. The 
short sprints mimic the repeated rushes between points 
of cover during a combat situation (Harman et al. 2008). 
Each participant began in a two point stance at the edge 
of the firing range in full combat gear (combat vest with 
ammunition, helmet, and assault rifle). Upon a verbal com-
mand the participant sprinted around a cone 15-m away 
and returned to the firing range. Each participant sprinted 
to a designated spot and lay prone on the ground as quickly 
as possible and delivered three shots to a target 30-m away. 
All targets were headshots and each shot that hit the tar-
get was considered accurate. Participants had 5-s to deliver 
three shots to the target. Upon completion of the three 
shots each participant pivoted and returned to the starting 
line and repeated the sprint and shooting sequence. A total 
of five sprint and shooting rounds were completed (a total 
of 15 shots were delivered onto the target). For safety pur-
poses participants did not sprint with their assault rifle. All 
sprints were performed on a sand and dirt surface. All tim-
ing was performed with a stopwatch that measured time to 
the nearest 1/100th of a second, and the same investigator 
conducted all sprint trials during PRE and POST testing. 
The number of accurate shots was recorded.
Cognitive function
Immediately following the repeated sprints and shooting 
performance participants performed a modified version of 
the original Serial Sevens Test to analyze cognitive func-
tion (Hayman 1942). The test consisted of a 2-min timed 
written test in which participants were required to subtract 
the number 7 from a randomly generated four digit num-
ber, in order to measure how quickly and accurately they 
can compute a simple mathematical problem. The four 
digit number appeared on the top of the first column of a 
three column sheet of paper. Participants were provided the 
sheet of paper and asked to complete as many calculations 
as possible in the 2-min period. The answers to the calcula-
tions were written underneath the initial number. Regard-
less of answer provided, participants were then required to 
subtract the number 7 from that new number. Participants 
were not told if their answer was correct or not. The num-
ber of correct answers was recorded. Intraclass correlations 
for this assessment has been determined in our laboratory 
to be R > 0.81 (Wells et al. 2013). The test was conducted 
next to the firing range, and the range remained ‘hot’ (i.e., 
continuous shooting) throughout the 2-min test.
Supplement schedule
The β-alanine supplement (CarnoSyn™) was obtained from 
Natural Alternatives International (San Marcos, CA, USA). 
Both the supplement and placebo were in tablet form and 
were similar in appearance. Participants in the supplement 
group were provided with 2 tablets of sustained-release 
β-alanine at a dose of (2 g per serving) three times per day 
(total β-alanine intake was 6 g per day) and subjects in the 
placebo group were provided with an equivalent amount of 
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rice powder. Participants were instructed to consume the 
supplement following their meals with water. Each partici-
pant was provided with a bottle containing a week’s supply 
of tablets. All bottles were returned at the end of the week. 
All tablets left in the bottle were counted, recorded, and the 
next week’s bottle was provided to the participant. Supple-
mentation occurred every day over a 30-day period.
Statistical analysis
Data was analyzed using a 2 × 2 [treatment (BA, PL) × 
time (PRE, POST)] repeated measures analysis of vari-
ance. In the event of a significant F ratio, LSD post hoc 
comparisons were used. POST–PRE (∆) performance 
changes between groups were analyzed using an unpaired 
t test. Due to logistical issues only 10 of the 18 participants 
were able to have their muscle and brain carnosine concen-
trations assessed at the PRE assessment. Therefore, com-
parisons of ∆ carnosine content was analyzed using the 
non-parametric independent samples median test. An alpha 
level of p ≤ 0.05 was considered statistically significant 
for all comparisons. Spearman rank correlation analysis 
was used to examine the relationship between changes in 
carnosine content and performance measures. All data are 
reported as mean ± SD. Data were analyzed using SPSS 
v20 software (SPSS Inc., Chicago, IL).
Results
Compliance for consuming the supplement or placebo was 
100 %. No adverse events were reported from participants 
in either group during the duration of the study. Body mass 
of the participants did not change (p = 0.500) from PRE 
(74.2 ± 5.7 kg) to POST (74.1 ± 5.8 kg) assessments, and 
no differences were noted in comparisons between groups.
Comparisons in the ∆ carnosine content within the gas-
trocnemius muscle are shown in Fig. 1. Baseline carno-
sine content (6.7 ± 2.2 mM) in both groups was similar 
to that previously published (Baguet et al. 2010; Stelling-
werff et al. 2012). Significant elevations (p = 0.048) from 
baseline was noted in BA compared to PL. Changes in the 
carnosine content of the gastrocnemius was moderately 
correlated to changes in fatigue rate in the 1-min sprint 
(r = 0.633, p = 0.060). Although these correlations were 
not statistically different they did indicate a trend towards 
a relationship between the change in muscle carnosine con-
tent and rate of fatigue. In regards to brain carnosine con-
tent, no changes were observable (p = 0.607) from PRE 
levels in either group. Considering the limit of detection in 
the 3 Tesla magnet is approximately 0.5 mM, it is likely 
that there was not a sufficient degree of sensitivity to dis-
cern any changes in brain carnosine content.
Comparisons between BA and PL in the measures 
examined during the 2.5 km run are described in Table 1. 
No significant differences were noted between the groups 
in the time for the 2.5 km run (p = 0.866), average velocity 
(p = 0.944) and average heart rate (p = 0.122). In addition, 
no significant differences were noted between the groups 
in the percent of distance run at low, (p = 0.873), medium 
(p = 0.502) and high intensity (p = 0.605).
Results of all sprint performance measures are depicted 
in Table 2. During the 1-min sprint no significant differ-
ence (p = 0.723) was observed in the total distance run 
from PRE (310.0 ± 16.7 m vs. 310.7 ± 23.7 m) to POST 
(302.4 ± 21.2 m vs. 306.6 ± 17.2 m) in either BA or PL, 
respectively, and no between group differences were noted 












Fig. 1  Changes in ∆ carnosine content in the gastrocnemius. All 
data are reported as mean ± SD. *Significant difference (p < 0.05) 
between groups, BA β-alanine, PL placebo
Table 1  Performance variables during the 2.5 km run
All data are reported as mean ± SD
BA β-alanine group, PL placebo group
Variable Group PRE POST p value
Time (s) BA 624 ± 22.6 629 ± 23.8 0.866
PL 633 ± 25.3 609 ± 36.4
Average Velocity 
(ms−1)
BA 3.97 ± 0.17 4.09 ± 0.25 0.944
PL 3.94 ± 0.14 4.05 ± 0.24
Average heart rate 
(beats min−1)
BA 156.8 ± 15.5 165.7 ± 6.1 0.122
PL 162.1 ± 11.7 159.3 ± 11.4
Distance run at low 
intensity (%)
BA 12.3 ± 12.0 10.7 ± 14.0 0.873
PL 15.2 ± 12.6 12.3 ± 14.9
Distance run at moder-
ate intensity (%)
BA 69.8 ± 12.1 65.1 ± 14.8 0.502
PL 71.1 ± 10.9 63.7 ± 14.7
Distance run at high 
intensity (%)
BA 18.4 ± 12.4 23.9 ± 20.1 0.645
PL 13.3 ± 9.2 23.9 ± 20.2
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were noted in peak or mean velocity, fatigue rate and 
the distance run at 90 % of peak velocity. In addition, no 
between group differences were noted in any of the meas-
ured variables.
Changes in the ∆ time for the 50-m casualty carry 
are depicted in Fig. 2. Participants in BA significantly 
(p = 0.044) improved their time for the sprint compared 
to PL. No differences were noted between the groups in 
average time or fatigue rate during the 30-m repeated sprint 
protocol (see Table 2). In addition, no differences from PRE 
to POST were noted in marksmanship for BA (14.0 ± 0.8 
shots on target and 13.1 ± 2.3 shots on target, respectively) 
or PL (13.2 ± 1.7 shots on target and 12.9 ± 1.6 shots on 
target, respectively), and no between group differences 
(p = 0.755) were noted as well. However, a significant 
difference (p = 0.022) was observed in the serial subtrac-
tion test under stress (see Table 2; Fig. 3). Ingestion of 
β-alanine for 30-days appeared to significantly improve 
Table 2  Performance variables 
during the sprint protocols and 
serial subtraction test
All data are reported as 
mean ± SD
BA β-alanine group, PL placebo 
group
Assessment Variable Group PRE POST p value
1-min sprint Peak velocity (ms−1) BA 6.68 ± 0.36 6.57 ± 0.18 0.354
PL 6.71 ± 0.48 6.77 ± 0.43
Average velocity (ms−1) BA 5.21 ± 0.28 5.09 ± 0.36 0.535
PL 5.19 ± 0.33 5.15 ± 0.29
Fatigue rate (%) BA 32.5 ± 5.5 30.9 ± 6.7 0.893
PL 32.2 ± 7.1 30.1 ± 5.4
Distance run at 90 %  
peak velocity
BA 69.5 ± 4.1 58.5 ± 7.7 0.199
PL 66.0 ± 6.0 60.8 ± 7.5
Repeat 30-m sprints Average sprint time (s) BA 7.42 ± 0.24 8.00 ± 0.29 0.780
PL 7.43 ± 0.26 8.00 ± 0.22
Fatigue rate (%) BA 91.6 ± 4.8 91.8 ± 3.0 0.432
PL 93.8 ± 1.8 92.4 ± 3.2
50-m casualty carry Time (s) BA 15.60 ± 1.16 15.34 ± 0.97 0.044
PL 14.64 ± 0.73 14.86 ± 0.85
Serial subtraction Number of correct responses (#) BA 27.1 ± 8.2 31.9 ± 7.9 0.022

















Fig. 2  Changes in ∆ 50-m Casualty Carry. All data are reported as 































Fig. 3  Changes in ∆ serial subtraction test. All data are reported as 
mean ± SD. *Significant difference (p < 0.05) between groups, BA 
β-alanine, PL placebo
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50-m casualty carry time and serial subtraction test perfor-
mance compared to placebo.
Discussion
Results of this study demonstrate that 30-days of β-alanine 
ingestion was effective in elevating muscle carnosine con-
tent in the gastrocnemius muscle of elite combat soldiers 
during a period of high intensity training. In addition, the 
increase in β-alanine ingestion appeared to improve 50-m 
casualty carry time and cognitive performance (i.e., serial 
subtraction test). These results appear to confirm a recent 
investigation that supported the benefit of β-alanine inges-
tion on military personnel (Hoffman et al. 2014), and are 
consistent with current knowledge regarding elevations in 
muscle carnosine content.
Changes in muscle carnosine content in the gastrocne-
mius muscle was similar to that reported by Derave et al. 
(2007), but greater than that reported by Baguet et al. 
(2010). This difference may be related to training experi-
ence. Recent research has reported that trained muscle is 
more sensitive for synthesizing carnosine than untrained 
muscle (Bex et al. 2014). The study by Baguet et al. (2010) 
examined rowers who primarily exercised their upper body 
musculature, but the investigators measured carnosine con-
tent in the gastrocnemius muscle. In contrast, Derave et al. 
(2007) examined the gastrocnemius muscle group in ath-
letes whose training and performance were focused primar-
ily with the lower body. Similarly, the conditioning activ-
ity of the participants in this present study was primarily 
comprised of lower body activities (e.g., runs, marches and 
sprints).
Significant performance improvements were only noted 
in the 50-m casualty carry, but no significant changes were 
observed between BA and PL in the 2.5 km run, 1-min 
sprint or the repeated sprints and shooting. Based upon the 
physiological role of carnosine in muscle, these results are 
not surprising. Although elevations in muscle carnosine 
may enhance the ability to perform high intensity interval 
training that can indirectly enhance endurance performance 
(Smith et al. 2009), the limited number of studies examin-
ing β-alanine supplementation and traditional endurance 
training have not shown any efficacy in β-alanine ingestion 
and endurance performance (Hoffman et al. 2014; Jordan 
et al. 2010). The inconsistency seen in the high intensity 
performance measures supports the results of a recent 
meta-analysis that indicated that greatest ergogenic poten-
tial for elevated muscle carnosine concentrations occurs 
during high intensity exercise lasting 60–240 s in duration 
(Hobson et al. 2012).
The lack of any effect of BA ingestion on repeated sprint 
performance is similar to previous studies that used similar 
supplement dosages and duration of use in repeated sprint 
activity (Saunders et al. 2012; Sweeney et al. 2010). The 
duration of each sprint (7.43 ± 0.24 s) and the relatively 
low total number of sprints (e.g., five) was unlikely to gen-
erate a significant decline in muscle pH. The longer dura-
tion 50-m casualty carry though did result in a significant 
performance improvements for BA compared to PL. Fol-
lowing the 30-day supplement period, participants con-
suming β-alanine performed the sprint faster than those 
participants consuming the placebo. Although the duration 
of the sprint ranged from 13.72 to 17.18 s the added resist-
ance provided by sprinting with a manikin in dirt and sand 
added a significant stress to the anaerobic energy system. 
The 60 kg manikin was approximately 81 % of the body 
mass of the average participant. A load of this magnitude 
has been shown to significantly enhance the metabolic cost 
associated with activity (Knapik et al. 2004), and is a stress 
commonly reported among infantry soldiers who carry 
between 29 and 60 kg in their backpacks during various 
military specific tasks (Nindl et al. 2013).
No significant differences were noted between BA and 
PL in any performance variable measured during the 1-min 
sprint. However, the moderate correlation (r = 0.633) 
noted between the change in muscle carnosine content 
and fatigue rate during sprint is consistent with previous 
studies examining fatigue rate and β-alanine supplementa-
tion (Derave et al. 2007; Stout et al. 2006). Regardless, no 
differences were noted between the groups in peak veloc-
ity, mean velocity, distance run for one-min, distance run 
at 90 % of peak velocity or fatigue rate during the 1-min 
sprint. Although the duration of the sprint was 1 min, this is 
at the low end of what is suggested to be the threshold for 
performance efficacy regarding β-supplementation (Hob-
son et al. 2012). It is likely that this range of performance 
times is specific to the training program utilized. Recom-
mendations regarding β-alanine use is generally focused 
on the anaerobic athlete (Hoffman et al. 2012; Sale et al. 
2010), however the physical preparation of the tactical ath-
lete examined in this present study was focused primar-
ily on endurance activity. Although many of the job task 
requirements of the combat soldier have been determined 
to be anaerobic in nature (Knapik et al. 2009), the training 
program of many combat soldiers are not job task specific 
(Nindl et al. 2013). It is likely that the non-anaerobic and/
or non-competitive athlete may be limited in their ability to 
perform prolonged sprinting. Further analysis of the GPS 
data during the 1-min sprint revealed that the percentage of 
time spent sprinting (>6.11 ms−1) was similar between the 
groups, but only 15.3 ± 7.3 % of the total time recorded 
was actually considered to be at a rate consistent with a 
sprint.
In contrast to a recent study demonstrating improved 
marksmanship and target engagement speed following 
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4-weeks of β-alanine ingestion (Hoffman et al. 2014), this 
present study was unable to observe any between group 
differences. However, the shooting protocol between the 
studies was quite different. In the previous study, partici-
pants were required to overcome a misfire in their weapon 
and then continue to direct fire at their target 40-m away 
as rapidly as possible. A 24.8 % difference was noted in 
the time required to deliver 10 shots onto the target. In this 
study, participants fired three times on target between each 
sprint. There were no pre-arranged misfires and each par-
ticipant had 5-s to deliver a volley of three shots to a target 
of shorter distance (30-m). This was performed to simulate 
close quarters combat in which soldiers move rapidly from 
cover to cover exchanging fire. Previous research has sug-
gested that even in a fatigued state shooting accuracy can 
be maintained (Nibbeling et al. 2013), but shooting distance 
may change. In this present study, distance of the shooting 
remained consistent throughout the protocol. In addition, 
the previous study demonstrating improved marksmanship 
skills with β-alanine may have been related to improved 
cognitive ability under stress rather than reduced fatigue 
alone. Overcoming the misfire required the participant to 
focus and operate in a manner that determined the reason 
for the misfire, correct it and then continue shooting. This 
study did not include the same cognitive stress to the shoot-
ing protocol.
The current study reported significant improvements 
in cognitive performance, as assessed by the 2-min serial 
subtraction test. This contrasted with the lack of difference 
in this measure reported previously following 4-weeks of 
β-alanine ingestion (Hoffman et al. 2014). The differences 
between this present study and the previous investigation 
by Hoffman et al. (2014) may be in the manner in which 
the serial subtraction test was administered. In the previ-
ous study, participants sat down in a quiet area whereas 
in the present study, participants performed the test at the 
shooting range with continuous fire still being directed at 
targets. The participants in this present study were required 
to maintain their focus despite the active firing line that 
was occurring near them. The loud noise of the firing range 
coupled with the stress of performing mathematical prob-
lems may have contributed to a high level of anxiety within 
the participants. A recent study has indicated that anxiety 
can significantly decrease cognitive performance, and spe-
cifically mathematical skills in infantry soldiers (Nibbeling 
et al. 2014). The results of this present study indicate that 
30-days of β-alanine ingestion enhance cognitive function 
to a greater extent than a placebo.
The mechanism that was potentially hypothesized to 
enhance cognitive function as a result of β-alanine inges-
tion focused on elevating brain carnosine levels. Previous 
research has suggested that β-alanine intake can increase 
carnosine content in the brain, which appears to result in an 
anxiolytic effect (Murakami and Furuse 2010). However, 
this was shown in a murine model and has not been pre-
viously demonstrated in humans. To date, carnosine con-
tent in the human brain has been reported to exist in the 
olfactory bulb only (Boldyrev et al. 2013). This anatomi-
cal region of the brain is primarily responsible for sense of 
smell, and the potential ergogenic effects related to carno-
sine levels in the olfactory bulb are not well understood. 
However, the parieto-occipital region though, which was 
examined in the present study, is responsible for processing 
visual and sensory information that is critical in the deci-
sion-making processes for the tactical athlete. However, to 
our knowledge no studies have been published examining 
the ability of β-alanine ingestion to increase carnosine lev-
els in this region of the brain. This is likely related to the 
limitations of existing technology which makes it difficult 
to determine whether the peak on the MRS spectrum of the 
brain is carnosine only or also homocarnosine. Homocar-
nosine is a histidine containing dipeptide consisting of his-
tidine and GABA and is thought to be more prevalent in 
the human brain than carnosine (Boldyrev et al. 2013). The 
impetus to investigate brain carnosine content in this study 
was predicated on the assumption that any changes in the 
spectrum would be attributed solely to an increase in car-
nosine as a result of β-alanine ingestion. Considering that 
the participants garrisoned together and were provided the 
same meals during the entire study, the assumption was that 
any change in the peak area at ~8.0 ppm of the spectrum 
in the brain measures could be only related to supplement 
ingestion. Considering that no change was noted between 
the groups it is likely that the sensitivity of MRS was not 
sufficient to detect carnosine changes that are of smaller 
magnitude than that seen in skeletal tissue.
A potential mechanism that can explain the improved 
cognitive function observed in this study can thus be only 
left to speculation. One possibility is that increases in car-
nosine may have elevated BDNF. BDNF is the most prev-
alent neurotrophin in the central nervous system where it 
supports existing neurons and promotes neuronal growth 
(Park and Poo 2012). Murakami and Furuse (2010) have 
demonstrated that increases in brain carnosine can elevate 
BDNF concentrations resulting in greater anxiolytic activ-
ity. Another possible role of carnosine in the brain has 
suggested that it acts as a reservoir for histidine, which is 
a precursor for histamine (Zhu et al. 2007). Decreases in 
histidine has been demonstrated to reduce brain histamine 
levels and subsequently increase anxiety-like behaviors 
(Yoshikawa et al. 2014), reduce cognitive function (Dai 
et al. 2007) and contribute to stress and depression (Yanai 
et al. 1998). When histamine levels are elevated levels 
of anxiety appear to be reduced (Endou et al. 2001), and 
memory task capability appears to be maintained (Benetti 
and Izquierdo 2013). It is possible that when carnosine is 
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synthesized in the brain, it is quickly hydrolyzed to histi-
dine and β-alanine by the enzyme carnosinase. Two iso-
forms of the enzyme were discovered with one form spe-
cifically found in the liver and brain (Jackson et al. 1991). 
However, others have suggested that an increased expres-
sion of carnosinase in the brain may actually have greater 
pathophysiological implications by decreasing carnosine 
levels and increasing risk of oxidative stress (Bellia et al. 
2009). Clearly, additional work is needed in our under-
standing of carnosine synthesis in the brain from β-alanine 
ingestion.
In conclusion, the results of this study indicate that 30 
days of β-alanine ingestion in soldiers of an elite combat 
unit can increase muscle carnosine content and improve 
50-m casualty carry time. Further, changes in muscle car-
nosine content were moderately correlated to changes in 
fatigue rate during prolonged sprint activity. Although 
cognitive performance under stressful conditions were 
significantly greater in participants consuming β-alanine 
compared to placebo, the current study methods were 
unable to detect any change in brain carnosine levels, thus 
the precise mechanism underlying these effects remains 
elusive.
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